The association of neuroleptic sensitivity in Lewy body disease with a false positive clinical diagnosis of Creutzfeldt-Jakob disease

International Journal of Geriatric Psychiatry

Volumn 21, Issue 11, 2006, Pages 1031-1035

  Lemstra, A W ^a   Schoenmaker, N ^a   Rozemuller Kwakkel, A J M ^a   van Gool, W A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Creutzfeldt Jakob disease; Dementia with Lewy Bodies; Neuroleptic sensitivity; Neuropathology

Indexed keywords

AMANTADINE; AMITRIPTYLINE; ATYPICAL ANTIPSYCHOTIC AGENT; BIPERIDEN; BROMPERIDOL; CLOZAPINE; DIAZEPAM; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; PERGOLIDE; PIPAMPERONE; RISPERIDONE; SELEGILINE; SERTRALINE;

ADULT; AGED; APRAXIA; ARTICLE; ATAXIA; AUTOPSY; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; CONFUSION; COORDINATION DISORDER; CORTICAL SENSORY APHASIA; CREUTZFELDT JAKOB DISEASE; DEHYDRATION; DEMENTIA; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DROWSINESS; DRUG SENSITIVITY; DYSARTHRIA; DYSPHAGIA; ELECTROENCEPHALOGRAM; EXTRAPYRAMIDAL SYMPTOM; FASCICULATION; FEMALE; GAZE PARALYSIS; GENERAL CONDITION DETERIORATION; HUMAN; HUMAN TISSUE; INCONTINENCE; MALE; MEDICAL RECORD REVIEW; MENTAL DETERIORATION; MOTOR DYSFUNCTION; MUTISM; MYOCLONUS; NEUROIMAGING; NEUROLEPTIC MALIGNANT SYNDROME; OROFACIAL DYSKINESIA; PYRAMIDAL SIGN; RESTLESSNESS; TACHYCARDIA; TACHYPNEA; UNCONSCIOUSNESS; VISUAL HALLUCINATION;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; CREUTZFELDT-JAKOB SYNDROME; DIAGNOSTIC ERRORS; FEMALE; HUMANS; LEWY BODY DISEASE; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RETROSPECTIVE STUDIES;

EID: 33751099289     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.1602     Document Type: Article

References (9)

1. Ballard C, Grace J, McKeith I, Holmes C. 1998. Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease. Lancet 351: 1032-1033.
2. Haik S, Brandel JP, Sazdovitch V, et al. 2000. Dementia with Lewy bodies in a neuropathologic series of suspected Creutzfeldt-Jakob disease. Neurology 55: 1401-1404.
3. McKeith I, Fairbairn A, Perrry R, Thompson P, Perry E. 1992a. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ 305: 673-678.
4. McKeith IG, Perry RH, Fairbairn AF, et al. 1992b. Operational criteria for senile dementia of Lewy body type (SDLT). Psycholog Med 22: 911-922.
5. McKeith IG, Galasko D, Kosaka K, et al. 1996. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB). Neurology 47: 1113-1124.
6. Masters CL, Harris JO, Gajdusek DC, et al. 1979. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 5: 177-188.
7. Poser S, Mollenhauer B, Krauss A, et al. 1999. How to improve the clinical diagnosis of Creutzfeldt-Jakob disease. Brain 122: 2345-2351.
8. Tschampa HJ, Neumann M, Zerr I, et al. 2001. Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 71: 33-39.
9. Zerr I, Bodemer M, Gefeller O, et al. 1998. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 43: 32-40.